Novo Nordisk has reported new data with its long-acting human growth hormone (hGH) product Sogroya, showing it is at least as effective as its older drug Norditropin in various paediatric growth ...

Novo Nordisk has reached the end of its two-year suspension from the Association of the British Pharmaceutical Industry (ABPI) for breaches of its code of practice, after showing "significant and ...

Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European Medicines Agency for approval, with one in three trial participants ...

Read about Novo Nordisk AS ADR (NVO:XNYS) stock and today's latest news and financial updates.

Review Novo Nordisk AS ADR (NVO:XNYS) stock and the current sustainability and ESG risk rating to help with your investing decisions.